Popliteal Artery Disease Clinical Trial
- Prospective, multi-center, single-arm registry study
- A total of 100 subjects with isolated popliteal artery lesions according to inclusion
and exclusion criteria will be enrolled.
- All popliteal artery lesions will be treated with drug-eluting balloon (In.PACT Admiral,
Medtronic). • Atherectomy or use of bare nitinol stent in combination with drug-eluting
balloon is allowed • Patients will be followed clinically for 12 months after the
procedure.
- Imaging study (Duplex ultrasound, CT angiography or catheter angiography) follow-up will
be performed at 12 months.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04546477 -
Prospective Multicenter Study to Confirm the Performance of the Renzan Stent in Treatment of SFA/POP Artery Disease
|
N/A |